Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

Observational, Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 1 or Type 2 Diabetes Mellitus

This study is conducted in Europe. The aim of this observational study is to evaluate the incidence of serious adverse drug reactions while using Levemir® under normal clinical practice conditions.

Inclusion Criteria:

• Type 1 diabetes
• Type 2 diabetes
• Candidates of use of a basal insulin as part of their diabetes regimen

Exclusion Criteria:

• Unwilling to adhere to therapy or follow up
• Pregnancy